glyceryl 2-arachidonate

cannabinoid receptor 1 ; Homo sapiens







128 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
51 26218440 Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. 2015 Oct 1
52 26271952 The Endocannabinoid System and its Modulation by Phytocannabinoids. 2015 Oct 1
53 26343051 Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis. 2015 Sep 6 1
54 26494286 Fetal endocannabinoids orchestrate the organization of pancreatic islet microarchitecture. 2015 Nov 10 4
55 24324206 2-arachidonoylglycerol effects in cytotrophoblasts: metabolic enzymes expression and apoptosis in BeWo cells. 2014 Mar 1
56 24361301 Endocannabinoid signalling in neuronal migration. 2014 Feb 2
57 24721209 2-Arachidonoylglycerol modulates human endothelial cell/leukocyte interactions by controlling selectin expression through CB1 and CB2 receptors. 2014 Jun 3
58 24747340 Endocannabinoid-mediated retrograde modulation of synaptic transmission. 2014 Dec 1
59 24882055 Stress regulates endocannabinoid-CB1 receptor signaling. 2014 Oct 2
60 24935942 Increased angiotensin II contraction of the uterine artery at early gestation in a transgenic model of hypertensive pregnancy is reduced by inhibition of endocannabinoid hydrolysis. 2014 Sep 1
61 25011912 Docking based virtual screening and molecular dynamics study to identify potential monoacylglycerol lipase inhibitors. 2014 Aug 15 2
62 25030704 Endocannabinoids modulate cortical development by configuring Slit2/Robo1 signalling. 2014 Jul 17 1
63 25169670 Control of synaptic function by endocannabinoid-mediated retrograde signaling. 2014 1
64 25427281 2-Arachidonoylglycerol enhances platelet formation from human megakaryoblasts. 2014 1
65 22947916 Modulation of sweet responses of taste receptor cells. 2013 Mar 4
66 23169348 The volitional nature of nicotine exposure alters anandamide and oleoylethanolamide levels in the ventral tegmental area. 2013 Mar 1
67 23485612 Endogenous lipid activated G protein-coupled receptors: emerging structural features from crystallography and molecular dynamics simulations. 2013 Apr 1
68 23512546 Chemical probes of endocannabinoid metabolism. 2013 Apr 2
69 21418147 The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors. 2012 Feb 1
70 22087025 Cannabinoid receptor type 1 (CB1) activation inhibits small GTPase RhoA activity and regulates motility of prostate carcinoma cells. 2012 Jan 2
71 22113346 Cannabinoid-2 receptor activation protects against infarct and ischemia-reperfusion heart injury. 2012 Apr 1
72 22289914 Endocannabinoids at the synapse a decade after the dies mirabilis (29 March 2001): what we still do not know. 2012 May 15 1
73 22827915 Developmental trajectory of the endocannabinoid system in human dorsolateral prefrontal cortex. 2012 Jul 24 1
74 22842590 Cannabinoids inhibit peptidoglycan-induced phosphorylation of NF-κB and cell growth in U87MG human malignant glioma cells. 2012 Oct 1
75 21187104 Ghrelin-induced activation of cAMP signal transduction and its negative regulation by endocannabinoids in the hippocampus. 2011 May 4
76 21256197 Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults. 2011 Mar 31 5
77 21562266 The endogenous cannabinoid 2-arachidonoylglycerol is intravenously self-administered by squirrel monkeys. 2011 May 11 3
78 21693703 Cannabinoid receptor type 1 (CB1R) signaling regulates hepatic gluconeogenesis via induction of endoplasmic reticulum-bound transcription factor cAMP-responsive element-binding protein H (CREBH) in primary hepatocytes. 2011 Aug 12 2
79 21863215 Cannabinoid receptor type I modulates alcohol-induced liver fibrosis. 2011 2
80 21919868 The emerging role of the endocannabinoid system in the sleep-wake cycle modulation. 2011 Sep 1 2
81 22103420 DAGL-dependent endocannabinoid signalling: roles in axonal pathfinding, synaptic plasticity and adult neurogenesis. 2011 Nov 1
82 20156559 The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after spinal cord injury. 2010 May 2
83 20204561 Role of cannabinoids in the development of fatty liver (steatosis). 2010 Jun 2
84 20426869 Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients. 2010 Apr 28 1
85 20525978 Effect of anaesthesia and cardiopulmonary bypass on blood endocannabinoid concentrations during cardiac surgery. 2010 Aug 2
86 20797687 Mutations in ABHD12 cause the neurodegenerative disease PHARC: An inborn error of endocannabinoid metabolism. 2010 Sep 10 2
87 20878765 The constitutive production of the endocannabinoid 2-arachidonoylglycerol participates in oligodendrocyte differentiation. 2010 Dec 1
88 19285258 The brain endocannabinoid system in the regulation of energy balance. 2009 Feb 1
89 19319851 Physiological roles of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. 2009 Jan-Feb 1
90 19372200 Minireview: Endocannabinoids and their receptors as targets for obesity therapy. 2009 Jun 1
91 19419760 Endocannabinoid system in first trimester placenta: low FAAH and high CB1 expression characterize spontaneous miscarriage. 2009 Jun 2
92 17704191 The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling. 2008 Jan 1
93 17965731 Compartmentalization of endocannabinoids into lipid rafts in a dorsal root ganglion cell line. 2008 Jan 2
94 18234884 Enzymatic machinery for endocannabinoid biosynthesis associated with calcium stores in glutamatergic axon terminals. 2008 Jan 30 1
95 18302793 Binding mode prediction of conformationally restricted anandamide analogs within the CB1 receptor. 2008 Feb 26 1
96 18316020 Cannabinoids provoke alcoholic steatosis through a conspiracy of neighbors. 2008 Mar 1
97 18452279 Full mass spectrometric characterization of human monoacylglycerol lipase generated by large-scale expression and single-step purification. 2008 May 2
98 18534982 Endocannabinoid 2-arachidonoylglycerol protects neurons by limiting COX-2 elevation. 2008 Aug 15 3
99 18571623 A COX-2 metabolite of the endogenous cannabinoid, 2-arachidonyl glycerol, mediates suppression of IL-2 secretion in activated Jurkat T cells. 2008 Aug 1 2
100 18597752 Aqueous humor outflow effects of 2-arachidonylglycerol. 2008 Aug 3